Bavarian Nordic

Bavarian Nordic Struggles to Supply Monkeypox Shot

To meet surging global demand for its Jynneos-branded monkeypox vaccine, Danish biotech Bavarian Nordic (BN) is pulling out all stops. Strategies include outsourcing production of other vaccines to CDMOs and exploring the reuse of millions of doses that have technically expired but are still viable.

Bavarian Nordic Wins Contract for Monkeypox Vaccine

As Europe and North America face a potential monkeypox outbreak, Danish biotech Bavarian Nordic has won a contract to supply its smallpox vaccine to an unnamed European country.

GSK Sells Travel Vaccines to Bavarian Nordic

Bavarian Nordic Wins Janssen Ebola Subcontract